Geneblitz is a registered trademark belonging to Complement Genomics Ltd, a long established, reliable, highly recommended and trusted DNA testing and molecular analysis company.
The Geneblitz service has primarily been designed to serve the CRO and pharmaceutical sector with state of the art genotyping and phenotyping for clinical trials. We work from phase I through to post marketing surveillance at GCP.
As a result of customer requests, we have developed service provision in nucleic acid extraction, bio-banking, biomarker discovery and most importantly, biomarker validation.
We continue to work with our long established customers in the field of forensics (human and animal) and DNA sequencing.
An exciting addition to our portfolio is microbial analysis by NGS.
We have for 15 years worked on human DNA testing, both business to business via www.dadcheckgold.com and business to consumer (www.dadchecksilver.com and www.thatdnacompany.com). This includes paternity and relationship questions using DNA testing technology and our UK based ISO/IEC 17025 accredited laboratories are accredited by the UK Ministry of Justice for section 20 paternity testing.
Recent addition to our portfolio is Chxout, a dedicated service for non human DNA testing. This is focused on avian testing, food authentication and environmental genetics (www.chxout.com).
We are also research active in both human and non human genetic and biomarker testing and have recently been involved in a major project with the National Institute for Health Research examining the biomarkers which can predict healing in the diabetic foot ulcer.
We are based in the prestigious Durham Genome Centre (www.durhamgenome.com).
Louise is a post graduate in Medical Genetics, having carried our research into the genetics of colon cancer. Louise is responsible for the day to day running of the company and is the designated Quality Manager. She is excited about the future for the company...with several new service lines coming on stream, new products in development and the commercial use of molecular analysis burgeoning, the prospects are bright.
"Molecular analysis is moving into a new and exciting era. Genotyping and biomarker technologies are becoming mainstream and our team of experienced molecular biologists are here to help you achieve your goals". Louise Allcroft, CEO, June 2015.
Maria is responsible for the delivery of the ChXout service and is an expert molecular geneticist who is skilled in STR profiling, bio banking and bioinformatics.
Neil has been involved in genetic testing and molecular biology for over 30 years and is the author of over 40 original publications and three books. His current role in the company is in new business development and marketing.